1995
DOI: 10.1002/hon.2900130103
|View full text |Cite
|
Sign up to set email alerts
|

Interleukin‐10 production by a B‐cell line derived from human post‐transplant lymphoproliferative disease

Abstract: Interleukin-10 (IL-10) is a cytokine known to regulate growth and differentiation in activated human B cells. We studied IL-10 production in a B-cell line derived from Epstein-Barr virus associated post-transplant lymphoproliferative disease (PTLD). Reverse transcriptase polymerase chain reaction (RT-PCR) demonstrated IL-10 mRNA within the cells. Transcripts of the virally encoded homologue BCRF-1 were not detected. ELISA assays demonstrated translation of IL-10 message into the corresponding cytokine, and its… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
7
0

Year Published

1997
1997
2005
2005

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 12 publications
1
7
0
Order By: Relevance
“…The data presented here show that posttransplant lymphoproliferative diseasederived cells resemble LCLs and BL cell lines in that they are refractory to exogenously added interleukin-10. The lack of effect of anti-interleukin-10 on cell proliferation confirms our preliminary observation that interleukin-10 may not have an autocrine growth regulatory role in posttransplant lymphoproliferative disease (Randhawa et al, 1995). The immunosuppressive properties of interleukin-10, evidenced by its ability to suppress IL-1, IL-6, and TNF-a production by monocytes (Malefyt et al, 1991a;Malefyt et al, 1991b), could, however, interfere with host defense mechanisms directed against Epstein-Barr-virus-infected posttransplant lymphoproliferative disease cells in vivo.…”
Section: Discussionsupporting
confidence: 85%
“…The data presented here show that posttransplant lymphoproliferative diseasederived cells resemble LCLs and BL cell lines in that they are refractory to exogenously added interleukin-10. The lack of effect of anti-interleukin-10 on cell proliferation confirms our preliminary observation that interleukin-10 may not have an autocrine growth regulatory role in posttransplant lymphoproliferative disease (Randhawa et al, 1995). The immunosuppressive properties of interleukin-10, evidenced by its ability to suppress IL-1, IL-6, and TNF-a production by monocytes (Malefyt et al, 1991a;Malefyt et al, 1991b), could, however, interfere with host defense mechanisms directed against Epstein-Barr-virus-infected posttransplant lymphoproliferative disease cells in vivo.…”
Section: Discussionsupporting
confidence: 85%
“…Thus, MMF treatment with or without the addition of steroids may be expected to have beneficial effects not only on acute but also on chronic rejection as a result of suppression of IL-10 secretion. Furthermore, MMF might reduce the incidence of PTLD because IL-10 seems to play a role in Epstein Barr virus-associated PTLD (41)(42)(43).…”
Section: Discussionmentioning
confidence: 99%
“…Studies have shown that the earliest T cell precursor in the thymus has the capacity to generate into B cells [40,41], and IL-10 also regulates human B cell growth and differentiation [42]. It has been speculated that chronic overexpression of IL-10 may play a central role in the pathogenesis at University of North Dakota on June 4, 2015 http://jid.oxfordjournals.org/ Downloaded from of B cell lymphomas [43], which are characteristic of late-stage infection with both HIV and FIV.…”
Section: Discussionmentioning
confidence: 99%